A number of heriditary neural diseases such as Lou Gehrig syndrome (Amyotyrophic Lateral Sclerosis) are typified by a late onset of motor neuron degeneration and loss of function. In C. elegans mutations in
dpy-20 gene have been described previously (Hosono et al., 1982; Clark et al., 1995) that range from a small size, hypodermal defects, abnormal head morphology and lethality. Here we report that
dpy-20 encodes a novel inhibitor of transcription in motor neurons (Fukushige and Siddiqui, 1995), that is selectively expressed during post-embryonic development. A
dpy-20::lacZ reporter gene was constructed and shown to express in the ventral cord motor neurons and hypodermal cells (Ali et al., WBG 15, 51-53, 1998). Temporal expression pattern of the reporter gene is consistent with the temperature shift experiments using a
dpy-20(
e1282)ts allele (Clark et al., 1995), that suggests that the gene is transcribed increasingly in larval development from the late L1 stage to L3 larval stage, and is not expressed in adults. In situ RNA hybridization data on early embryos and germ line cells suggests that the
dpy-20 gene is not transcribed during embryogenesis or during germ line development, suggesting its expression limited to the post-embryonic larval development. Since severe alleles of
dpy-20 display defective locomotion, we have tested expression of the
dpy-20::lacZ gene in a variety of mutant backgrounds that show abnormal locomotion. We have also examined expression of reporter genes that are known to express in the ventral cord motor neurons in
dpy-20 mutant background. Our results suggest that there is a strong genetic interaction between
dpy-20 and a variety of genes that express in motor neurons and hypodermal cells. Finally, the amino acid sequence deduced from the cloned
dpy-20 gene does not show a significant homology to any protein in data bases; however, we find that the DPY-20 harbors several motifs that are conserved in transcription factors and regulatory proteins. Although DPY-20 has no homeobox sequence, it has 41% simailrity with LIN-39 transcription factor(Kenyon,1994) of C. elegans.We thank J.Miwa, Y. Kohara, R. Holmgren, A. Otsuka, R. Hosono, K. Harada, and K.Nishikawa for help in this work.